By quantitative PCR and western blot, we confirmed that the established RU and RR cells derived from the three TNBC cell lines exhibited very low expression levels of SOX2, compared to the estrogen receptor-positive breast cancer cell lines (Figure 2C). This evidence concerns the gene SOX2 and breast cancer.